PUMA BIOTECHNOLOGY, INC. Unrecognized Tax Benefits that Would Impact Effective Tax Rate
PUMA BIOTECHNOLOGY, INC. (PBYI) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $8.80 million as of 2017-12-31, per its 10-K filed 2019-03-01.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2019-03-01
- 2017-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $8.80M; Unrecognized Tax Benefits that Would Impact Effective Tax Rate as first filed $7.20M.
- 2015-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $0.00.
- 2014-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $0.00.
- 2013-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $0.00.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate as first filed |
|---|---|---|
| 2017-12-31 | $8.80M 10-K · filed 2019-03-01 | $7.20M 10-K · filed 2018-03-09 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-01 | |
| 2014-12-31 | $0.00 10-K · filed 2015-03-02 | |
| 2013-12-31 | $0.00 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |